Evidence map›Paper›PMID 35631126›Full record

ArticlePathogens (Basel, Switzerland)2022

Inhibitor of Cysteine Protease of

Hương Giang Lê, Jung-Mi Kang, Tuấn Cường Võ, Thảo Dương Nguyễn, Myunghwan Jung, Min Kyoung Shin, Won Gi Yoo, Byoung-Kuk Na

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hương Giang LêDepartment of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.
Jung-Mi KangDepartment of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.
Tuấn Cường VõDepartment of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.
Thảo Dương NguyễnDepartment of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.
Myunghwan JungDepartment of Convergence Medical Science, Gyeongsang National University, Jinju 52727, Korea.ORCID 0000-0001-8124-8945
Min Kyoung ShinDepartment of Convergence Medical Science, Gyeongsang National University, Jinju 52727, Korea.ORCID 0000-0003-1782-5351
Won Gi YooDepartment of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0002-3041-5560
Byoung-Kuk NaDepartment of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0002-6734-1673
Gyeongsang National University · KR

Funding

National Research Foundation of Korea NRF-2021R1I1A1A01048499
6 · The paper itself

Abstract

Cysteine proteases of malaria parasites have been recognized as potential targets in antimalarial drug development as they play pivotal roles in the biology of these parasites. However, strict regulation of their activities is also necessary to minimize or prevent deleterious damage to the parasite and the host. Previously, we have characterized falcipain family cysteine proteases of

Indexed as

cathepsinshemoglobin hydrolysisinhibitor of cysteine proteasemalapainsPlasmodium malariae

Identifiers

PMID35631126
PMCPMC9142985
OpenAlexW4281258696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.